Synergie Aubépine Melisse Tilleul
Food supplement declared in France, declaration No 2024-7-1485, decision dated 23 July 2024
Synergie Aubépine Melisse Tilleul, from MENIGOZ GAEL, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Crataegus monogyna 1 ml per day, Melissa officinalis 1 ml per day, Tilia × 1 ml per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- MENIGOZ GAEL
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Autre : gouttes
- Daily dose
- 60 gouttes (3 ml)
- Directions for use
- 15 à 20 gouttes trois fois par jour diluées dans un verre d'eau
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep, Nervous system
Declaration 328157, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Crataegus monogyna Jacq. | Sommités fleuries | Alcoolature | 1 ml |
| Melissa officinalis L. | Feuille | Alcoolature | 1 ml |
| Tilia × europaea L. | Feuille | Alcoolature | 1 ml |
Other ingredients
Alcool éthylique, Eau potable
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Crataegus monogyna Jacq.
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
- Melissa officinalis L.
Read the warning, when it applies and the studies cited
LEMON BALM -MELISSA OFFICINALIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Synergie Aubépine Melisse Tilleul: composition and regulation”, https://compoatlas.com/en/supplements/products/328157-synergie-aubepine-melisse-tilleul, updated 15 November 2026.